These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32789675)

  • 1. Rapastinel alleviates the neurotoxic effect induced by NMDA receptor blockade in the early postnatal mouse brain.
    Vasilescu AN; Mallien A; Pfeiffer N; Lang UE; Gass P; Inta D
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1587-1591. PubMed ID: 32789675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.
    Donello JE; Banerjee P; Li YX; Guo YX; Yoshitake T; Zhang XL; Miry O; Kehr J; Stanton PK; Gross AL; Burgdorf JS; Kroes RA; Moskal JR
    Int J Neuropsychopharmacol; 2019 Mar; 22(3):247-259. PubMed ID: 30544218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapastinel, an NMDAR positive modulator, produces distinct behavioral, sleep, and EEG profiles compared with ketamine.
    Banerjee P; Donello JE; Hare B; Duman RS
    Behav Brain Res; 2020 Aug; 391():112706. PubMed ID: 32461133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain.
    Inta I; Vogt MA; Vogel AS; Bettendorf M; Gass P; Inta D
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):673-7. PubMed ID: 26482736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain.
    Lima-Ojeda JM; Vogt MA; Pfeiffer N; Dormann C; Köhr G; Sprengel R; Gass P; Inta D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():28-33. PubMed ID: 23643674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants.
    Wang YT; Zhang NN; Liu LJ; Jiang H; Hu D; Wang ZZ; Chen NH; Zhang Y
    Biochem Biophys Res Commun; 2022 Feb; 594():46-56. PubMed ID: 35074585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
    Kato T; Duman RS
    Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.
    Burgdorf J; Zhang XL; Weiss C; Gross A; Boikess SR; Kroes RA; Khan MA; Burch RM; Rex CS; Disterhoft JF; Stanton PK; Moskal JR
    Neuroscience; 2015 Nov; 308():202-11. PubMed ID: 26343295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.
    Burgdorf J; Kroes RA; Zhang XL; Gross AL; Schmidt M; Weiss C; Disterhoft JF; Burch RM; Stanton PK; Moskal JR
    Behav Brain Res; 2015 Nov; 294():177-85. PubMed ID: 26210936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-type specific modulation of NMDA receptors triggers antidepressant actions.
    Pothula S; Kato T; Liu RJ; Wu M; Gerhard D; Shinohara R; Sliby AN; Chowdhury GMI; Behar KL; Sanacora G; Banerjee P; Duman RS
    Mol Psychiatry; 2021 Sep; 26(9):5097-5111. PubMed ID: 32488125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.
    Rajagopal L; Burgdorf JS; Moskal JR; Meltzer HY
    Behav Brain Res; 2016 Feb; 299():105-10. PubMed ID: 26632337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the activity of
    Vasilescu AN; Schweinfurth N; Borgwardt S; Gass P; Lang UE; Inta D; Eckart S
    Neuropsychiatr Dis Treat; 2017; 13():973-980. PubMed ID: 28408831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential.
    Vasilescu AN; Pfeiffer N; Terraneo F; Riva MA; Lang UE; Inta D; Gass P
    Int J Neuropsychopharmacol; 2022 Nov; 25(11):946-950. PubMed ID: 35974297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.
    Moskal JR; Burgdorf JS; Stanton PK; Kroes RA; Disterhoft JF; Burch RM; Khan MA
    Curr Neuropharmacol; 2017; 15(1):47-56. PubMed ID: 26997507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals.
    Tremblay R; Chakravarthy B; Hewitt K; Tauskela J; Morley P; Atkinson T; Durkin JP
    J Neurosci; 2000 Oct; 20(19):7183-92. PubMed ID: 11007874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice.
    Rajagopal L; Huang M; He W; Ryan C; Elzokaky A; Banerjee P; Meltzer HY
    Behav Brain Res; 2022 Aug; 432():113964. PubMed ID: 35718230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Deoxysphingolipid-induced neurotoxicity involves N-methyl-d-aspartate receptor signaling.
    Güntert T; Hänggi P; Othman A; Suriyanarayanan S; Sonda S; Zuellig RA; Hornemann T; Ogunshola OO
    Neuropharmacology; 2016 Nov; 110(Pt A):211-222. PubMed ID: 27016021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.
    Khan MA; Houck DR; Gross AL; Zhang XL; Cearley C; Madsen TM; Kroes RA; Stanton PK; Burgdorf J; Moskal JR
    Int J Neuropsychopharmacol; 2018 Mar; 21(3):242-254. PubMed ID: 29099938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.
    Carter K; Dickerson J; Schoepp DD; Reilly M; Herring N; Williams J; Sallee FR; Sharp JW; Sharp FR
    Neuropharmacology; 2004 Dec; 47(8):1135-45. PubMed ID: 15567423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.